Pharmaceutical Value proposition
[Automatic translation follows] Chugai Pharmaceutical Co., Ltd., headquartered in Tokyo, is a research-based pharmaceutical company with world-class drug discovery capabilities, including proprietary antibody engineering technologies. Chugai is committed to creating innovative pharmaceutical products that may satisfy unmet medical needs. Chugai is listed on the Prime Market of the Tokyo Stock Exchange. While maintaining autonomy and management independence, Chugai is an Important member of the Roche Group. Additional information is available at https://www.chugai-pharm.co.jp/english/
Read our Social Media Policy: https://www.chugai-pharm.co.jp/english/rule/sns/index.html
Chugai Pharmaceutical (head office: Tokyo) is a research and development-based pharmaceutical company that has its strengths in its unique drug discovery technology base, including antibody engineering technology. As an important member of the Roche Group, as a listed company on the Tokyo Stock Exchange Prime Market, under independent management, we are committed to creating innovative pharmaceuticals that meet unmet medical needs.
Please refer to our social media policy before using:
https://www.chugai-pharm.co.jp/rule/sns/index.html
Pharmaceuticals, new drug development, global companies, biopharmaceuticals, biotechnology, innovation, and healthcareOriginal language
Chugai Pharmaceutical Co., Ltd., headquartered in Tokyo, is a research-based pharmaceutical company with world-class drug discovery capabilities, including proprietary antibody engineering technologies. Chugai is committed to creating innovative pharmaceutical products that may satisfy unmet medical needs. Chugai is listed on the Prime Market of the Tokyo Stock Exchange. While maintaining autonomy and management independence, Chugai is an important member of the Roche Group. Additional information is available at https://www.chugai-pharm.co.jp/english/
Read our Social Media Policy: https://www.chugai-pharm.co.jp/english/rule/sns/index.html
中外製薬(本社:東京)は、抗体エンジニアリング技術をはじめ独自の創薬技術基盤を強みとする、研究開発型の製薬企業です。ロシュ・グループの重要なメンバーであるとともに、東京証券取引所プライム市場の上場企業として、自主独立経営の下、アンメットメディカルニーズを満たす革新的な医薬品の創製に取り組んでいます。
ご利用にあたってはソーシャルメディアポリシーをご覧ください:
https://www.chugai-pharm.co.jp/rule/sns/index.html
製薬, 新薬開発, グローバル企業, バイオ医薬品, pharmaceuticals, biotechnology, innovation, and healthcare
中外製薬株式会社：創造で、想像を超える。
中外製薬株式会社：創造で、想像を超える。
https://www.chugai-pharm.co.jp/
| Entity | Type | Tweets | Articles | |
|---|---|---|---|---|
 | Osaka University Research Services, deeptech | Other 27 Mar 2025 | | |
 | 4BIO Capital Venture Capital and Private Equity Principals | Other 31 Jan 2025 | | |
 | redalpine Venture Capital and Private Equity Principals | Other 31 Dec 2024 | | |
 | Pureos Bioventures | Other 11 Jan 2025 | | |
 | >>venture>> Startup Competition Non-profit Organizations | Other 12 Jan 2025 | | |
 | PSI Paul Scherrer Institut Research Services | Other 9 Jan 2025 | | |
 | Araris Biotech AG biotech, deeptech | Other 8 Jan 2025 | | |
 | Labiotech.eu Online Audio and Video Media | Other 9 Jan 2025 | | |
 | Deep Knowledge Analytics Research Services, it services | Other 31 Aug 2024 | | |
 | Klineo healthtech, deeptech | Other 16 Oct 2024 | | |